Mikami, Norihisa
Sakaguchi, Shimon
Article History
Accepted: 30 May 2023
First Online: 3 July 2023
Change Date: 4 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41581-023-00768-z
Competing interests
: S.S. is a founder and scientific advisor of RegCell, which aims to develop a novel T<sub>reg</sub> cell-based therapy for autoimmune disease. S.S. and N.M. are holders of a patent for use of a CDK8/19 inhibitor in T<sub>reg</sub> cell production.